Noked Capital LTD Kamada LTD Transaction History

Noked Capital LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.22 - $5.85 $70,676 - $97,975	-16,748 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.21 - $6.82 $87,257 - $114,221	16,748 New	16,748 $110,000
Q3 2021 Nov 12, 2021	SELL	$5.25 - $5.87 $87,927 - $98,310	-16,748 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$6.02 - $8.06 $246,242 - $329,686	-40,904 Reduced 70.95%	16,748 $104,000
Q4 2020 Feb 12, 2021	SELL	$6.3 - $8.46 $412,618 - $554,087	-65,495 Reduced 53.18%	57,652 $374,000
Q3 2020 Nov 13, 2020	BUY	$8.02 - $11.73 $987,638 - $1.44 Million	123,147 New	123,147 $1.03 Million

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $260M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Noked Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Noked Capital LTD with notifications on news.